ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Aprepitant, a Neurokinin-1 Receptor Antagonist, for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Randomized, Double-blind, Placebo Controlled Trial
The American Journal of Gastroenterology
◽
10.14309/00000434-201110002-00133
◽
2011
◽
Vol 106
◽
pp. S54
Author(s):
Tilak Shah
◽
Martin Poleski
◽
Stanley Branch
◽
Paul Jowell
◽
Jorge Obando
◽
...
Keyword(s):
High Risk
◽
Receptor Antagonist
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Neurokinin 1 Receptor
◽
High Risk Patients
◽
Risk Patients
◽
Neurokinin 1
Download Full-text
Related Documents
Cited By
References
Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered With Ondansetron for the Prevention of Postoperative and Postdischarge Nausea and Vomiting in High-Risk Patients
Survey of Anesthesiology
◽
10.1097/sa.0b013e31820eca68
◽
2011
◽
Vol 55
(2)
◽
pp. 94-97
Author(s):
&NA;
Keyword(s):
High Risk
◽
Receptor Antagonist
◽
Phase Ii
◽
Phase Ii Study
◽
Nausea And Vomiting
◽
Safety And Efficacy
◽
Neurokinin 1 Receptor
◽
High Risk Patients
◽
Risk Patients
◽
Neurokinin 1
Download Full-text
Efficacy of oral casopitant mesylate, a novel neurokinin-1 receptor antagonist, with intravenous ondansetron HCl in the prevention of postoperative nausea and vomiting (PONV) in high-risk patients
European Journal of Anaesthesiology
◽
10.1097/00003643-200606001-00573
◽
2006
◽
Vol 23
(Supplement 37)
◽
pp. 159-160
◽
Cited By ~ 1
Author(s):
N. Singla
◽
F. Chung
◽
S. Singla
◽
A. Grenier
◽
D. Kutsogiannis
◽
...
Keyword(s):
High Risk
◽
Receptor Antagonist
◽
Postoperative Nausea
◽
Postoperative Nausea And Vomiting
◽
Nausea And Vomiting
◽
Neurokinin 1 Receptor
◽
High Risk Patients
◽
Risk Patients
◽
Neurokinin 1
Download Full-text
Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trial
ACC Current Journal Review
◽
10.1016/j.accreview.2004.08.105
◽
2004
◽
Vol 13
(10)
◽
pp. 17
Author(s):
H.C. Diener
◽
J. Bogousslavsky
◽
L.M. Brass
Keyword(s):
Ischemic Stroke
◽
High Risk
◽
Transient Ischemic Attack
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
◽
Ischemic Attack
Download Full-text
Aspirin and Clopidogrel Compared With Clopidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Yearbook of Vascular Surgery
◽
10.1016/s0749-4041(08)70222-7
◽
2006
◽
Vol 2006
◽
pp. 289-290
Author(s):
G.L. Moneta
Keyword(s):
High Risk
◽
Ischaemic Stroke
◽
Transient Ischaemic Attack
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
◽
Ischaemic Attack
Download Full-text
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
The Lancet
◽
10.1016/s0140-6736(04)16721-4
◽
2004
◽
Vol 364
(9431)
◽
pp. 331-337
◽
Cited By ~ 1478
Author(s):
Hans-Christoph Diener
◽
Julien Bogousslavsky
◽
Lawrence M Brass
◽
Claudio Cimminiello
◽
Laszlo Csiba
◽
...
Keyword(s):
High Risk
◽
Ischaemic Stroke
◽
Transient Ischaemic Attack
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
◽
Ischaemic Attack
Download Full-text
Aspirin and Clopidogrel Compared With Clopidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Yearbook of Neurology and Neurosurgery
◽
10.1016/s0513-5117(08)70251-5
◽
2006
◽
Vol 2006
◽
pp. 28-30
Author(s):
A.A. Rabinstein
Keyword(s):
High Risk
◽
Ischaemic Stroke
◽
Transient Ischaemic Attack
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
◽
Ischaemic Attack
Download Full-text
Aspirin plus clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in patients at high risk patients (MATCH): Randomized double-blind placebo-controlled trial
Journal of Vascular Surgery
◽
10.1016/j.jvs.2004.10.007
◽
2004
◽
Vol 40
(6)
◽
pp. 1259
Author(s):
D Hans-Christoph
◽
J Bogousslavsky
◽
LM Brass
Keyword(s):
Ischemic Stroke
◽
High Risk
◽
Transient Ischemic Attack
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
◽
Ischemic Attack
Download Full-text
Randomized, Double-blind, Placebo-controlled Trial of Atenolol for the Prevention of Perioperative Myocardial Ischemia in High-risk Patients Scheduled for Noncardiac Surgery
Anesthesiology
◽
10.1097/00000542-199409001-00099
◽
1994
◽
Vol 81
(SUPPLEMENT)
◽
pp. A100
◽
Cited By ~ 1
Author(s):
A. Wallace
◽
E. Layug
◽
W. Browner
◽
M. Hollenberg
◽
U. Jain
◽
...
Keyword(s):
High Risk
◽
Myocardial Ischemia
◽
Controlled Trial
◽
Noncardiac Surgery
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
Download Full-text
Faculty Opinions recommendation of Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.735810391.793560626
◽
2019
◽
Author(s):
Eric Hoste
Keyword(s):
Randomized Controlled Trial
◽
High Risk
◽
Controlled Trial
◽
Contrast Induced Nephropathy
◽
Double Blind
◽
High Risk Patients
◽
Randomized Controlled
◽
Risk Patients
Download Full-text
A Phase II Multicenter Double-Blind Placebo-Controlled Study of Ethyl Pyruvate in High-Risk Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Journal of Cardiothoracic and Vascular Anesthesia
◽
10.1053/j.jvca.2008.08.005
◽
2009
◽
Vol 23
(3)
◽
pp. 324-329
◽
Cited By ~ 52
Author(s):
Elliott Bennett-Guerrero
◽
Madhav Swaminathan
◽
Alina M. Grigore
◽
Gary W. Roach
◽
Laura G. Aberle
◽
...
Keyword(s):
Cardiac Surgery
◽
Cardiopulmonary Bypass
◽
High Risk
◽
Phase Ii
◽
Ethyl Pyruvate
◽
Controlled Study
◽
Double Blind
◽
Double Blind Placebo
◽
High Risk Patients
◽
Risk Patients
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close